B103 DNA Polymerase Variants for Isothermal Amplification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for DNA polymerases with improved properties such as increased efficiency, specificity, yield, reduced sequence bias, and ability to function well at elevated temperatures and high salt conditions for applications like rolling circle amplification and whole genome amplification.

Innovation Solution

Development of DNA polymerase variants with specific amino acid substitutions, such as lysine replacing alanine at position 147 and glycine replacing alanine at position 318, which exhibit increased thermostability, reaction rate, and reduced bias in DNA amplification, allowing for efficient amplification at temperatures up to 42°C and improved yield.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If wild-type Phi29 DNA polymerase is used for DNA amplification, then the polymerase maintains stability and activity at lower temperatures, but the reaction rate and yield are limited, and sequence bias occurs

Engineering Contradiction:
Improvereaction rate and yield of DNA amplificationVSAvoidsequence bias and non-specific amplification
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies parameter changes by systematically modifying amino acid residues at specific positions (147, 221, 318, 339, 359, 372, 503, 511, 544, 550) in the Phi29 DNA polymerase sequence. These substitutions alter the enzyme's biochemical parameters to achieve improved reaction rate, yield, and reduced sequence bias while maintaining thermostability and specificity

Inventive Principle:
Principle #35Parameter changes

2Productivity

If the temperature is increased to improve reaction rate, then the amplification efficiency increases, but the polymerase loses stability and activity

Engineering Contradiction:
Improveamplification efficiency and reaction rateVSAvoidpolymerase stability at elevated temperatures
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent modifies the polymerase's amino acid composition to change its thermal stability parameters. Specific substitutions at positions such as 147, 221, and 318 enable the enzyme to maintain structural stability and catalytic activity at elevated temperatures (37-42°C), thereby decoupling the trade-off between temperature-induced rate enhancement and enzyme denaturation

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If standard Phi29 DNA polymerase is used, then the amplification works well at low temperatures, but non-specific amplification and background artifacts increase

Engineering Contradiction:
Improveamplification at low temperaturesVSAvoidnon-specific amplification and background artifacts
Core Design Contradiction:
Ease of operationVSObject-generated harmful factors

Solution Approach 1:

The patent introduces amino acid substitutions that modify the polymerase's specificity parameters. Changes at positions including 318, 359, and 544 enhance the enzyme's discrimination between specific and non-specific templates, reducing background artifacts and non-specific amplification while preserving the ability to function at low temperatures

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS11371028B2Variant DNA polymerases having improved properties and method for improved isothermal amplification of a target DNA
Publication Date: 2022.06.28 NEW ENGLAND BIOLABS INC
  • US11371028B2 patent drawing
  • US11371028B2 patent drawing
  • US11371028B2 patent drawing

AI summary

Variants of the bacteriophage B103 DNA polymerase are described herein. The variant has improved properties, that include when compared to wild-type Phi29 DNA polymerase, at least one of the following: increased thermostability, improved reaction rate for DNA amplification, reduced background and a reduction of bias. Methods of using the DNA polymerase variant are also described herein.